Jan 10, 2024 / 05:00PM GMT
Jessica Fye J.P. Morgan-Moderator
Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JP Morgan, and we're continuing the 42' Annual Healthcare Conference today with Immunocore. I'm joined on stage by the company's CEO, Bahija Jallal. She's going to give a presentation on the business, and then we're going to go into Q&A. (Operator Instructions) So with that, let me pass it over to Bahija.
Bahija Jallal Immunocore Holdings plc-CEO&Director
All right. Good morning, everyone. Thank you, Jess, for having us. I would like to start with a patient story. A few days ago, we met this very vibrant CEO. She was diagnosed seven years before with uveal melanoma, metastatic uveal melanoma. Her doctor said, only a few months to your daughter's graduation, but actually, you're not going to make it to that graduation. She enrolled into KIMMTRAK, and she lived seven years to tell her story. This is always what reminds me why we come to work every day, and what a privilege to be doing what we do.
So let's
Immunocore Holdings PLC at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers